Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Argikar AA"'
Autor:
Kulkarni PR; Takeda Pharmaceuticals International, Cambridge, MA, USA., Youssef AS; GlaxoSmithKline, Collegeville, PA, USA., Argikar AA; Synteract Inc, Morrisville, NC, USA. Aneesh.Argikar@synteract.com.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2021; Vol. 2342, pp. 369-417.
Autor:
Argikar AA; a Department of Pharmacokinetics , KinderPharm LLC , Exton , PA , USA., Argikar UA; b Department of Pharmacokinetic Sciences , Novartis Institutes for BioMedical Research, Inc , Cambridge , MA , USA.
Publikováno v:
Drug metabolism reviews [Drug Metab Rev] 2018 Aug; Vol. 50 (3), pp. 398-405. Date of Electronic Publication: 2018 Jul 16.
Autor:
Brantley SJ; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, North Carolina (S.J.B.); Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania (A.A.A., S.N.); Department of Pharmaceutics, University of Washington, Seattle, Washington (Y.S.L.); and College of Pharmacy, Washington State University, Spokane, Washington (M.F.P.)., Argikar AA, Lin YS, Nagar S, Paine MF
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2014 Mar; Vol. 42 (3), pp. 301-17. Date of Electronic Publication: 2013 Dec 11.